Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-004716

Options or other derivatives

  • Chief Financial Officer acquired 13,888 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cook Kevin Leon Chief Financial Officer 2022-02-11 Grant or award · Restricted Stock Units +13,888 13,888 D: show line 1 in the form
Loading xslF345X03/ownership.xml…